
651
Downloads
16
Episodes
The Canadian Biomarker Integration Network for Depression (CAN-BIND) has a podcast! We lead a series of groundbreaking studies in depression aimed at shortening the path from diagnosis to getting the right treatment.
The Canadian Biomarker Integration Network for Depression (CAN-BIND) has a podcast! We lead a series of groundbreaking studies in depression aimed at shortening the path from diagnosis to getting the right treatment.
Episodes

3 days ago
3 days ago
30 min
Could psychedelics change the way we understand and treat mental health? From neuroscience to clinical care, these substances are prompting important questions about what we know and what we still have to learn.
In this episode, host Dr. Nirushi Kuhathasan speaks with Dr. Joshua Rosenblat, a psychiatrist and researcher at the University Health Network in Toronto, to explore the science behind psychedelics and their potential role in treatment. Together, they discuss how psychedelics affect the brain, what research tells us about their use in mental health care, and how our understanding of these substances continues to evolve. Tune in for a closer look at where the science stands and what the future could hold for psychedelic care in Canada.
Additional Reading:
Insights on Psilocybin for Clinicians: https://jamanetwork.com/journals/jama/fullarticle/2853938
Insights on Psilocybin for Patients: https://jamanetwork.com/journals/jama/fullarticle/2854042
Ketamine for Bipolar Depression: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2853662
Blinding in Psychedelic Clinical Trials: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2847667
Host: Dr. Nirushi Kuhathasan
Guests: Dr. Joshua Rosenblat
Producer: Dr. Nirushi Kuhathasan
Audio Editor: Serhii Artiukh
Music: Teamwork by scottholmesmusic.com
3 days ago
30 min

No comments yet. Be the first to say something!